We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Neuroplasticity Device Helps Recover Muscle Control

By HospiMedica International staff writers
Posted on 15 Feb 2018
Print article
Image: An EMG feedback device helps stroke patients recover muscle control (Photo courtesy of Zynex).
Image: An EMG feedback device helps stroke patients recover muscle control (Photo courtesy of Zynex).
A novel device helps stroke and spinal cord injury patients regain movement by using the brain's ability to rewire itself.

The Zynex (Lone Tree, CO, USA) NeuroMove 900 device is designed to detect signals sent by the patient’s brain to a certain muscle group by analysis of electromyography (EMG) readings using two adhesive electrodes. A built-in microprocessor distinguishes when an EMG signal represents regular muscle activity, muscle tone, noise, or a real attempt to move a muscle. When such a real attempt is detected, the unit “rewards” the patient with a few seconds of muscle contraction, with additional visual and sensory feedback serving as an important element in relearning the movement.

NeuroMove can detect attempts even when the trace movements are below visible levels, thus assisting healthy parts of the brain assume lost functionality. NeuroMove also prompts the patient to relax just as often (a significant element in learning to control a muscle group), as better relaxation of a muscle group can sometimes be noticed just ten minutes into a treatment session. The system adjusts automatically to the levels produced by each patient and to each new session, making it effective both for patients with spasticity/muscle tone, as well as for patients with flaccid extremities.

“Stroke is the leading cause of serious, long-term disability in the United States and the NeuroMove 900 is uniquely positioned to enhance the patient's recovery,” said Thomas Sandgaard, founder and CEO of Zynex. “Under a newly designed marketing strategy, healthcare practitioners will be able to use the NeuroMove 900 on patients clinically and then easily transition the patient's rehabilitation to the patient's home once discharged from the clinic.”

EMG is an electrodiagnostic technique for evaluating and recording the electrical activity produced by skeletal muscles when electrically or neurologically activated in order to detect neurological and neuromuscular problems. It is used diagnostically to study biomechanics, motor control, neuromuscular physiology, movement disorders, postural control, and for physical therapy.

Related Links:
Zynex

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscope
EB-500

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.